DrugPatentWatch Database Preview

CLEOCIN Drug Profile

« Back to Dashboard

When do Cleocin patents expire, and when can generic versions of Cleocin launch?

Cleocin is a drug marketed by Pharmacia And Upjohn and is included in fourteen NDAs. There is one patent protecting this drug.

This drug has twenty-four patent family members in twenty-two countries.

The generic ingredient in CLEOCIN is clindamycin palmitate hydrochloride. There are fifty-five drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the clindamycin palmitate hydrochloride profile page.

Summary for CLEOCIN

International Patents:	24
US Patents:	1
Applicants:	1
NDAs:	14
Suppliers / Packagers:	3
Bulk Api Vendors:	67
Clinical Trials:	8
Patent Applications:	1,106
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for CLEOCIN
DailyMed Link:	CLEOCIN at DailyMed

Pharmacology for CLEOCIN

Drug Class	Lincosamide Antibacterial
Physiological Effect	Decreased Sebaceous Gland Activity

Synonyms for CLEOCIN

[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate;hydrochloride

[(2R,4S,5R)-6-[2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate hydrochloride

[6-[2-chloro-1-[(1-methyl-4-propyl-pyrrolidine-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] hexadecanoate hydrochloride

25507-04-4

34850-73-2

35208-55-0 (Parent)

6-{2-chloro-1-[(1-methyl-4-propylpyrrolidin-2-yl)formamido]propyl}-4,5-dihydroxy-2-(methylsulfanyl)oxan-3-yl hexadecanoate hydrochloride

AB2000687

AB51459

AC-8823

AC1L1OVK

AKOS015963324

AKOS030242182

AN-7626

C-23416

C34H63ClN2O6S.HCl

C34H64Cl2N2O6S

CAS-25507-04-4

CHEBI:34647

CHEMBL1200632

Cleocin Pediatric

Cleocin pediatric (TN)

CLINDALYCIN PALMITATE HYDROCHLORIDE

Clindamycin 2-palmitate hydrochloride

Clindamycin palmitate HCl

CLINDAMYCIN PALMITATE HYDROCHLORIDE

Clindamycin palmitate hydrochloride (JAN/USP)

Clindamycin Palmitate Hydrochloride [USAN:JAN]

Clindamycin palmitate hydrochloride [USAN:USP:JAN]

Clindamycinpalmitatehydrochloride

CTK8F8720

D01990

DSSTox_CID_28660

DSSTox_GSID_48734

DSSTox_RID_82930

DTXSID3048734

J-016026

L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-2-hexadecanoate, monohydrochloride, (2S-trans)-

L-THREO-ALPHA-D-GALACTO-OCTOPYRANOSIDE, METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-[[(1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL]AMINO]-1-THIO-,2-HEXADECANOATE, MONOHYDROCHLORIDE, (2S-TRANS)-

LS-174102

METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-(1-METHYL-TRANS-4-PROPYL-L-2-PYRROLIDINECARBOXAMIDO)-1-THIO-L-THREO-ALPHA-D-GALACTO-OCTOPYRANOSIDE 2-HEXADECANOATE MONOHYDROCHLORIDE

Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-palmitate monohydrochloride

MolPort-003-983-293

MolPort-028-599-793

NCGC00185773-02

NSC-759141

NSC759141

O721

Pharmakon1600-01505470

s2596

SCHEMBL41416

Tox21_113175

U 25179E

U-25,179 E

UNII-VN9A8JM7M7

VN9A8JM7M7

US Patents and Regulatory Information for CLEOCIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmacia And Upjohn	CLEOCIN	clindamycin hydrochloride	CAPSULE;ORAL	061809-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Pharmacia And Upjohn	CLEOCIN T	clindamycin phosphate	GEL;TOPICAL	050615-001	Jan 7, 1987	AB	RX	Yes	Yes
Pharmacia And Upjohn	CLEOCIN	clindamycin phosphate	SUPPOSITORY;VAGINAL	050767-001	Aug 13, 1999		RX	Yes	Yes			Y
Pharmacia And Upjohn	CLEOCIN	clindamycin phosphate	CREAM;VAGINAL	050680-002	Mar 2, 1998	AB	RX	Yes	Yes
Pharmacia And Upjohn	CLEOCIN PHOSPHATE	clindamycin phosphate	INJECTABLE;INJECTION	061839-001	Approved Prior to Jan 1, 1982		DISCN	No	No

International Patents for CLEOCIN

Country	Document Number	Estimated Expiration
China	1360495
Japan	2003519095
Panama	8499101
Australia	6219800
European Patent Office	1200065

Supplementary Protection Certificates for CLEOCIN

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2013 00053	Denmark		PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
13/044	Ireland		PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
401	Luxembourg		PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
1304992/01	Switzerland		PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
2013025,C1304992	Lithuania		PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323